STOCKHOLM, Sweden, Oct. 19, 2005 (PRIMEZONE) -- Biotage AB:
-- Sales in the third quarter 2005 amounted to 126.6 MSEK
(84.5) and sales in the period January -- September 2005 to
292.0 MSEK (260.4).
-- The operating result for the third quarter amounted to
--20.6 MSEK (-26.2) and the operating result for the nine
month period to -58.3 MSEK (-62.3). Adjusted for non-recurring
items the operating result for the third quarter amounted to
-5.4 MSEK and the operating result for the period January --
September to -43.1 MSEK.
-- The net result for the third quarter amounted to -27.6 MSEK
(-31.4) and the net result for the first nine months amounted
to -40.3 MSEK (-63.9).
-- Earnings per share for the third quarter amounted to -0.39
SEK (-0.54) and earnings per share for the period January --
September to --0.61 SEK (-1.11).
-- In the third quarter there was a positive cash-flow from the
current business to the amount of 2 MSEK.
-- An Extraordinary General Meeting in August decided to authorize
the issue of new shares.
-- A directed share issue in September brought the company
approx. net 94 MSEK.
-- In September it was decided to make a new share issue with
preferential rights for the shareholders. The subscription
period is in November. If the issue is fully subscribed, the
company will gain approx. net 47 MSEK.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=141785&fn=wkr0001.pdf The full report
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=141785&fn=wkr0003.pdf Transition to IFRS Q3
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=141785&fn=wkr0004.pdf Comparison, IFRS, Iterim